Alnylam Pharmaceuticals
ALNY
#815
Rank
S$38.33 B
Marketcap
S$286.45
Share price
-1.43%
Change (1 day)
-53.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company